Understanding the Landscape of Immune Checkpoint Inhibitor Therapy in Early-Stage NSCLC: A Shared Decision-Making Resource for Clinicians and Patients

Download this patient-friendly PDF summarizing key points on using immune checkpoint inhibitors for early-stage NSCLC, from ongoing clinical trials to monitoring for and managing immune-related adverse events.
Elizabeth Krueger, NP
Format: Adobe Acrobat (.pdf)
File Size: 527 KB
Released: September 22, 2021

Information on this Educational Activity

Faculty

Elizabeth Krueger, NP

Nurse Practitioner
Thoracic Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Elizabeth Krueger, NP, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Related Content

Clinical Care Options (CCO) presents expert faculty discussing options for the treatment and care of patients with cancer during flu season.

person default Derrick W. Su, MD Released: November 22, 2022

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered lung and thyroid cancer

person default Saad A. Khan, MD Sandip P. Patel, MD Released: November 17, 2022

Expert slides on nursing care for patients receiving CAR T-cells, including managing acute and long-term toxicities, from Clinical Care Options (CCO)

person default Kathryn Ciccolini, DNP, AGACNP-BC, OCN Linda Ramsdell, MSN, FNP-BC, OCN Released: November 17, 2022

A patient describes her journey with early breast cancer and the critical role of good communication between patients and their healthcare providers in this short video by Clinical Care Options (CCO)

person default Zoe Lanham Released: November 16, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings